Premier US CRO with strong presence in C&E Europe
Cromos™ Pharma is a US-based CRO that specializes in phase I-IV clinical trials in North America, Central/Eastern Europe and in the post-Soviet states
As project managers, our "summa cum laude" MDs and PhDs don't just flawlessly adhere to a study protocol, they appreciate the science behind it. By choosing Cromos™ Pharma you get an invariable guarantee that your project will be handled by the "A-team"
Wide geographical coverage that guarantees rapid enrollment
Cromos™ Pharma has strong presence in US, Eastern Europe (Bulgaria, Czech Republic, Estonia, Hungary, Latvia, Lithuania, Poland, Romania and Slovakia) and post-soviet bloc (Armenia, Belarus, Geоrgia, Kazakhstan, Russia, Ukraine). Cromos™ Pharma has a proven track record of rapid patient recruitment and retention that often significantly exceeds other geographies

Our Key Differentiators

Rapid start-up
Our team of experts has years of experience working with the FDA on the most complicated protocols. In the ex-US territories, with its favorable regulatory environment coupled with in-depth local knowledge of submission guidelines and algorithms assures that, depending on the country, your study will be up and running within 8-20 weeks
Active patient recruitment and retention
By analyzing study population, sites’ motivation to enroll, type of disease, subjects’ barriers to participate in studies, we developed an active approach to resolving any the issues related to subject recruitment and retention
"No Patients - No Payments"
Rapid enrollment is supported by “No patients – no payments” initiative which assures that client reimburses Cromos Pharma only for enrolled patients and not for dormant, non-recruiting sites
Diligent Feasibility
Our experienced feasibility team will swiftly prepare a detailed capability/feasibility report and will suggest the best path forward, including country- and site-selection
Quality Management (Quality by Design)
We adhere to Quality by Design principles that include integrated planning, real-time project risk-based analysis and customer-focused optimization
Patients First
Welfare of our patients is our first priority. We are fully compliant with ICH-GCP and make sure that patients in our studies are well-informed, and have a direct line of communication to both the investigators and to our research team
CPR: Capability → Plan → Rescue
If your study is behind schedule or encounters difficulties with recruitment or retention of subjects, Cromos Pharma can provide comprehensive rescue plans to ensure original investments yield a return and that studies are efficiently concluded

OUR Mission

At Cromos™ Pharma our philosophy is simple – our patients and clients come first. We strive to assist our clients in advancement of their clinical development programs in order to improve the lives of our patients. Over the past 10 years we have molded our business model to reflect the most validated Western solutions which we carefully tailored to local environments. We are proud of our project managers who have terminal medical degrees, which mean that they don't just flawlessly adhere to study protocols, but also appreciate the science behind them. By choosing Cromos™ Pharma you get an invariable guarantee that your project will be handled by the "A-team" of our clinical research professionals. read more

Vlad Bogin, MD, FACP CEO


Christelle J. Project Manager, Big Pharma
Today I just wanted to give you a little feedback after several months working together. Just 2 words: THANK YOU!!!”
For the time we work together, I notice the efforts to respond to any of Sponsor’s request in a... Read more
Isabelle D. Project Manager, Orphan drug company
I would like to thank Cromos team for their effort in completing study enrolment with designated timelines in this complicated rare disease study!
Mark J. Director of Clinical Operations, Biotech
Based on my experience Cromos Pharma's patient recruitment concept really works – Cromos rescued enrollment in my study in melanoma and I am pleased to say "Thanks" to all members of the team, especially... Read more
Mary N. Global Project Manager, Pharma
I would mention your CRAs Irena M. and Alex A. who did a great job, were very proactive and we got good feedback on their performance from the sites as well.
John M. Chief Executive Officer, Biotech
I have been impressed with the proactivity and the desire to get things done that has been shown by each one of the Cromos Pharma team with whom I have interacted. My experience with Cromos Pharma has certainly been... Read more
Marc T. Chief Medical Officer, Biotech
Thank you for wrapping up the study on time. I want to say that your team did an exceptional work and we would not hesitate to you Cromos again in our future studies. Great job!
Dalyana K. Clinical Operations Manager, Big Pharma
I would like to recognize Cromos Pharma's team outstanding work and to express my sincere gratitude.
Thank you for your help during FDA inspection. You have displayed admirable characteristics which lead to a... Read more
Irene C. Medical Affairs Manager, Mid size Pharma
I want to thank you for the XXXX study. It is very important that we have met the timelines. I am sure that in many respects it is a credit of Helen S. I was touched by Helen’s personal approach, her deep knowledge of... Read more
Joanne R. Project Manager, US-based CRO
It is a pleasure to work with all of you at Cromos Pharma, This is our largest project together and you have outperformed yourselves again. We just got a word from the sponsor that they are extremely pleased with both... Read more
Elena D. Project Manager, Pharma
I would like to say my appreciation to clinical team and medical writer who did a great job during close-out period of the study which allowed to perform all necessary procedures and collect all required information in... Read more
Nicola S. Clinical Trial Manager, Big Pharma
I would like to thank XXXX study team for concerned efforts during start-up and enrollment. Enrollment target was achieved ahead of timelines and your country was the first which did it!!!
Lee M. Start-up Manager, Pharma
I was very impressed with feasibility team which managed to identify enough sites for such rare pathology. And additional thanks for collection all required documents from sites in such tight timelines.